Literature DB >> 7628519

Severe hypercholesterolaemia: unusual inheritance in an Italian pedigree.

G Zuliani1, G B Vigna, A Corsini, M Maioli, F Romagnoni, R Fellin.   

Abstract

A family presenting several cases of severe primary hypercholesterolaemia and/or premature sudden death was studied. This family is characterized by consanguinity, absence of vertical transmission, bimodal distribution of plasma cholesterol values, and reduction of reproductive fitness in affected individuals. The probands have clinical traits of homozygous familial hypercholesterolaemia, including hypercholesterolaemia, xanthomas and early coronary atherosclerosis, while the parents and grandparents are clinically normal. Eight relatives on the mother's side experienced premature sudden death, and in four cases hypercholesterolaemia was diagnosed. Haplotype segregation analysis of the inheritance of the LDL receptor and apo B genes in the probands' family excluded the involvement of these two genes in the pathogenesis of the disease. LDL receptor activity, as well as the ability of LDL to bind to the LDL receptor, and plasma vegetal sterols were within normal limits both in probands and in their relatives. The study of this pedigree suggests that hypercholesterolaemia is not produced by defects in the LDL receptor or LDL particles, and disease inheritance is consistent with an autosomal recessive trait.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7628519     DOI: 10.1111/j.1365-2362.1995.tb01709.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  11 in total

Review 1.  Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.

Authors:  R A Hegele
Journal:  Am J Hum Genet       Date:  2001-10-26       Impact factor: 11.025

Review 2.  Monogenic hypercholesterolemia: new insights in pathogenesis and treatment.

Authors:  Daniel J Rader; Jonathan Cohen; Helen H Hobbs
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

3.  Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia.

Authors:  Christopher Jones; Rita Garuti; Peter Michaely; Wei-Ping Li; Nobuyo Maeda; Jonathan C Cohen; Joachim Herz; Helen H Hobbs
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 4.  Single gene disorders causing ischaemic stroke.

Authors:  Saif S M Razvi; Ian Bone
Journal:  J Neurol       Date:  2006-06       Impact factor: 4.849

5.  A new locus for autosomal recessive hypercholesterolemia maps to human chromosome 15q25-q26.

Authors:  M Ciccarese; A Pacifico; G Tonolo; P Pintus; A Nikoshkov; G Zuliani; R Fellin; H Luthman; M Maioli
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

6.  The autosomal recessive hypercholesterolemia (ARH) protein interfaces directly with the clathrin-coat machinery.

Authors:  Sanjay K Mishra; Simon C Watkins; Linton M Traub
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-25       Impact factor: 11.205

7.  Sequence diversity in genes of lipid metabolism.

Authors:  C K Garcia; G Mues; Y Liao; T Hyatt; N Patil; J C Cohen; H H Hobbs
Journal:  Genome Res       Date:  2001-06       Impact factor: 9.043

8.  Characterization of a novel cellular defect in patients with phenotypic homozygous familial hypercholesterolemia.

Authors:  D Norman; X M Sun; M Bourbon; B L Knight; R P Naoumova; A K Soutar
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

9.  Use of homozygosity mapping to identify a region on chromosome 1 bearing a defective gene that causes autosomal recessive homozygous hypercholesterolemia in two unrelated families.

Authors:  E R Eden; R P Naoumova; J J Burden; M I McCarthy; A K Soutar
Journal:  Am J Hum Genet       Date:  2001-02-09       Impact factor: 11.025

10.  Identification of a VLDL-induced, FDNPVY-independent internalization mechanism for the LDLR.

Authors:  Peter Michaely; Zhenze Zhao; Wei-Ping Li; Rita Garuti; Lily J Huang; Helen H Hobbs; Jonathan C Cohen
Journal:  EMBO J       Date:  2007-06-21       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.